MX393209B - Particulas solidas de simeticona y forma de dosificacion de estas - Google Patents

Particulas solidas de simeticona y forma de dosificacion de estas

Info

Publication number
MX393209B
MX393209B MX2020003761A MX2020003761A MX393209B MX 393209 B MX393209 B MX 393209B MX 2020003761 A MX2020003761 A MX 2020003761A MX 2020003761 A MX2020003761 A MX 2020003761A MX 393209 B MX393209 B MX 393209B
Authority
MX
Mexico
Prior art keywords
dosage form
solid
simethicone particles
simethicone
particles
Prior art date
Application number
MX2020003761A
Other languages
English (en)
Other versions
MX2020003761A (es
Inventor
Christopher Szymczak
Gerard P Mcnally
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MX2020003761A publication Critical patent/MX2020003761A/es
Publication of MX393209B publication Critical patent/MX393209B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención está dirigida a partículas de simeticona microencapsulada que contienen simeticona y un revestimiento soluble en agua, en donde la simeticona es aproximadamente 50% en peso de la partícula.
MX2020003761A 2017-09-29 2018-09-14 Particulas solidas de simeticona y forma de dosificacion de estas MX393209B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762565850P 2017-09-29 2017-09-29
PCT/IB2018/057057 WO2019064112A1 (en) 2017-09-29 2018-09-14 SOLID PARTICLES OF SIMETHICONE AND THEIR DOSAGE FORM

Publications (2)

Publication Number Publication Date
MX2020003761A MX2020003761A (es) 2020-07-29
MX393209B true MX393209B (es) 2025-03-24

Family

ID=63713965

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003761A MX393209B (es) 2017-09-29 2018-09-14 Particulas solidas de simeticona y forma de dosificacion de estas

Country Status (11)

Country Link
US (1) US10722472B2 (es)
EP (2) EP4215187B1 (es)
JP (1) JP7282753B2 (es)
KR (1) KR102648960B1 (es)
CN (1) CN111132667A (es)
AU (1) AU2018343214B2 (es)
BR (1) BR112020005849A8 (es)
CA (1) CA3076413A1 (es)
MX (1) MX393209B (es)
PH (1) PH12020550113A1 (es)
WO (1) WO2019064112A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111389318B (zh) * 2020-04-17 2020-11-10 南京鼓楼医院 一种具备分子筛效应的互穿网络微胶囊制备方法
WO2022118107A1 (en) * 2020-12-03 2022-06-09 Johnson & Johnson Consumer Inc. Multi-layered particle comprising simethicone
CN113293129B (zh) * 2021-03-29 2022-06-17 浙江大学舟山海洋研究中心 一种促进成骨前体细胞增殖的功能肽混合粉及其应用
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition
GB2615103A (en) * 2022-01-27 2023-08-02 Anabio Tech Limited A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002332B (el) 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
JP2003505537A (ja) * 1999-07-20 2003-02-12 ザ、プロクター、エンド、ギャンブル、カンパニー 改良カプセル化油粒子
US6100245A (en) 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
CN1288730A (zh) 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
US6676933B2 (en) * 2001-05-23 2004-01-13 Osmotica Corp. Pharmaceutical composition containing mosapride and pancreatin
US7101573B2 (en) 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
MXPA06010972A (es) * 2006-09-25 2009-04-17 World Trade Imp Export Wtie Ag Proceso para estabilizacion de famotidina.
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone
EP2477614A2 (en) * 2009-09-17 2012-07-25 Cadila Healthcare Limited Pharmaceutical compositions for reducing alcohol-induced dose dumping

Also Published As

Publication number Publication date
EP4215187C0 (en) 2024-09-11
RU2020114918A3 (es) 2022-04-19
US10722472B2 (en) 2020-07-28
PH12020550113A1 (en) 2020-12-07
CA3076413A1 (en) 2019-04-04
KR20200061386A (ko) 2020-06-02
EP3687502A1 (en) 2020-08-05
KR102648960B1 (ko) 2024-03-20
BR112020005849A8 (pt) 2022-07-26
WO2019064112A1 (en) 2019-04-04
CN111132667A (zh) 2020-05-08
EP4215187A1 (en) 2023-07-26
RU2020114918A (ru) 2021-10-29
BR112020005849A2 (pt) 2020-10-06
EP3687502C0 (en) 2023-06-07
AU2018343214A1 (en) 2020-03-26
EP3687502B1 (en) 2023-06-07
EP4215187B1 (en) 2024-09-11
US20190099379A1 (en) 2019-04-04
AU2018343214B2 (en) 2023-10-05
MX2020003761A (es) 2020-07-29
JP7282753B2 (ja) 2023-05-29
JP2020535200A (ja) 2020-12-03

Similar Documents

Publication Publication Date Title
PH12020550113A1 (en) Solid simethicone particles and dosage form thereof
MX373742B (es) Composiciones para el cuidado personal que comprenden partículas de superficie modificada y silicona funcionalizada no volátil.
MX2020005783A (es) Sialil-lactosa secada por aspersion.
MX2016011897A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
MX2015013845A (es) Polvos secos de tiotropio.
BR112016023676A2 (pt) pó de sinterização com baixa pressão
NZ734035A (en) Nasal powder formulation for treatment of hypoglycemia
MX2018004154A (es) Agente matificante y metodo para obtener el mismo.
MY192425A (en) Polymorphs
MX2016005963A (es) Preparacion farmaceutica y metodo de su produccion y uso.
MX2017008210A (es) Elementos lubricantes que tienen componentes hidrofobos para cartuchos de rasuradora.
MX2021015514A (es) Compuesto heterociclico.
GEAP201814266A (en) Pyrazines modulators of gpr6
EA201691285A1 (ru) Композиция для ухода за волосами
PH12019500690A1 (en) Oral care composition
IN2013CH04500A (es)
MX2017008209A (es) Miembros lubricantes para cartuchos de rasuradora.
PH12016501984A1 (en) Agrochemical formulation
CL2018003587A1 (es) Composición de cal apagada en polvo altamente porosa.
GB2514741A (en) Composition for use as a paint binder
SA518391076B1 (ar) تركيبات طلاءات من البوليمر ذات حساسية منخفضة للاشتعال
PH12020552251A1 (en) Improved temperature-stable soft-magnetic powder
MY189081A (en) Powder coating
EA201991282A1 (ru) Исходный материал для напитка
WO2016071405A3 (en) Pharmaceutical preparation and method of its production and use